<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Arthroplast Today</journal-id><journal-id journal-id-type="iso-abbrev">Arthroplast Today</journal-id><journal-id journal-id-type="pmc-domain-id">3043</journal-id><journal-id journal-id-type="pmc-domain">artd</journal-id><journal-title-group><journal-title>Arthroplasty Today</journal-title></journal-title-group><issn pub-type="epub">2352-3441</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12240109</article-id><article-id pub-id-type="pmcid-ver">PMC12240109.1</article-id><article-id pub-id-type="pmcaid">12240109</article-id><article-id pub-id-type="pmcaiid">12240109</article-id><article-id pub-id-type="pmid">40636708</article-id><article-id pub-id-type="doi">10.1016/j.artd.2025.101743</article-id><article-id pub-id-type="pii">S2352-3441(25)00130-X</article-id><article-id pub-id-type="publisher-id">101743</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>What is the Association Between Nontobacco Nicotine Dependence and Postoperative Complications in Total Hip Arthroplasty? A Large Propensity-Matched Cohort Study</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name name-style="western"><surname>Good</surname><given-names initials="LM">Logan M.</given-names></name><degrees>MD</degrees><email>logan.good@uhhospitals.org</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref><xref rid="cor1" ref-type="corresp">&#8727;</xref></contrib><contrib contrib-type="author" id="au2"><name name-style="western"><surname>Blackburn</surname><given-names initials="CW">Collin W.</given-names></name><degrees>MD, MBA</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au3"><name name-style="western"><surname>Adelstein</surname><given-names initials="JM">Jeremy M.</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au4"><name name-style="western"><surname>Berk</surname><given-names initials="AN">Alexander N.</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au5"><name name-style="western"><surname>Florentino</surname><given-names initials="SA">Samuel A.</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au6"><name name-style="western"><surname>Jawanda</surname><given-names initials="HS">Harkirat S.</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au7"><name name-style="western"><surname>Cohen-Levy</surname><given-names initials="WB">Wayne B.</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><aff id="aff1"><label>a</label>Department of Orthopaedic Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA</aff><aff id="aff2"><label>b</label>Department of Orthopaedics, The MetroHealth System, Cleveland, OH, USA</aff><aff id="aff3"><label>c</label>Department of Orthopaedic Surgery, Case Western Reserve University School of Medicine, Cleveland, OH, USA</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8727;</label>Corresponding author. University Hospitals Cleveland Medical Center, Department of Orthopaedic Surgery, 11100 Euclid Ave, Cleveland, OH 44106, USA. Tel.: +1 440 752 0519. <email>logan.good@uhhospitals.org</email></corresp></author-notes><pub-date pub-type="collection"><month>8</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>23</day><month>6</month><year>2025</year></pub-date><volume>34</volume><issue-id pub-id-type="pmc-issue-id">491465</issue-id><elocation-id>101743</elocation-id><history><date date-type="received"><day>20</day><month>4</month><year>2025</year></date><date date-type="rev-recd"><day>5</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>12</day><month>5</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>23</day><month>06</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>09</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-10 11:25:52.703"><day>10</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Authors</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="abs0010"><sec><title>Background</title><p>Nontobacco nicotine dependence (NTND) is an increasing alternative to traditional tobacco use. However, limited data exist in NTND patients undergoing total hip arthroplasty (THA). The purpose of this study was to investigate differences in complications and revision rates among patients with and without NTND undergoing THA.</p></sec><sec><title>Methods</title><p>The TriNetX US Collaborative Network database was queried using ICD-10 and CPT codes to identify patients aged 18 and older undergoing primary THA between 2014 and 2024. Cohorts were divided depending on history of NTND and propensity-matched based on age, gender, race, ethnicity, body mass index, and comorbidities. Rates of complications and revision THA were compared.</p></sec><sec><title>Results</title><p>A total of 99,496,579 patients aged 18 and older were identified, of which 192,826 underwent primary THA. After exclusions, 15,561 (93.2%) were nonnicotine users and 8452 (6.8%) were NTND. After 1:1 propensity score matching, each cohort included 8378 patients. Complications including myocardial infarction, stroke, pneumonia, acute kidney injury, sepsis, emergency department visits, and rehospitalization were significantly higher at 90 days postoperatively in NTND patients (<italic toggle="yes">P</italic> &lt; .05). At 1 year postoperatively, in addition to these complications, the risk of postoperative deep vein thrombosis ([OR] 1.251; <italic toggle="yes">P</italic> = .0369) and infection (OR 1.288; <italic toggle="yes">P</italic> = .045) became significantly higher. Rates of prosthetic joint infection (OR 1.485; <italic toggle="yes">P</italic> = .004), revision THA (OR 1.868; <italic toggle="yes">P</italic> = .002), and death (OR 1.575; <italic toggle="yes">P</italic> = .035) were significantly elevated in NTND patients compared to their counterparts at 90 days, 1 year, and 5 years postoperatively.</p></sec><sec><title>Conclusions</title><p>NTND patients have higher rates of infection, revision, mortality, and postoperative complications including DVT, myocardial infarction, stroke, pneumonia, kidney injury, sepsis, infection, and return to the hospital. Providers should counsel NTND patients and consider screening protocols prior to operative management.</p></sec><sec><title>Level of Evidence</title><p>Retrospective cohort study, level of evidence III.</p></sec></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Nontobacco nicotine dependence (NTND)</kwd><kwd>Total hip arthroplasty (THA)</kwd><kwd>Postoperative complications</kwd><kwd>Revision total hip arthroplasty (THA)</kwd><kwd>Outcomes</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p id="p0010">Tobacco use is a known risk factor for complications after total hip (THA) and knee arthroplasty (TKA) [<xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>]. Prior studies have demonstrated increased risk for postoperative complications among cigarette smokers, including wound complications, prosthetic joint infection (PJI), and revision surgery [<xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>,<xref rid="bib9" ref-type="bibr">9</xref>]. Cigarette smoking influences both innate and adaptive immune responses, invariably leading to predispositions for localized and systemic infections [<xref rid="bib10" ref-type="bibr">10</xref>,<xref rid="bib11" ref-type="bibr">11</xref>]. Users of smokeless tobacco have also been reported to exhibit a perioperative risk profile similar to that of smokers [<xref rid="bib8" ref-type="bibr">8</xref>]. As a result, some authors have advocated for the cessation of tobacco products and nicotine testing before elective THA or TKA [<xref rid="bib12" ref-type="bibr">[12]</xref>, <xref rid="bib13" ref-type="bibr">[13]</xref>, <xref rid="bib14" ref-type="bibr">[14]</xref>].</p><p id="p0015">Nicotine alone has also been shown to cause extensive immune system dysregulation by inhibiting the secretion of many cytokines and altering immune cell function, negatively impacting the wound healing process [<xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib17" ref-type="bibr">[17]</xref>]. Nontobacco nicotine dependence (NTND) has become an alternative to traditional tobacco use with recent studies demonstrating increased prevalence in recent years [<xref rid="bib18" ref-type="bibr">[18]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>]. Nontobacco nicotine products may be inhaled, ingested orally, or administered transdermally. Nicotine is known to be the active ingredient of tobacco contributing to tissue hypoperfusion, epithelial dysfunction, immune dysregulation, and free radical production [<xref rid="bib21" ref-type="bibr">[21]</xref>, <xref rid="bib22" ref-type="bibr">[22]</xref>, <xref rid="bib23" ref-type="bibr">[23]</xref>]. As a result, nontobacco nicotine use may be associated with a perioperative risk profile similar to tobacco use.</p><p id="p0020">Recent studies have found NTND to be associated with higher risk for postoperative infection, deep vein thrombosis (DVT), sepsis, PJI, and revision procedure following primary TKA [<xref rid="bib24" ref-type="bibr">24</xref>]. To our knowledge, however, no prior studies have examined the risks of nontobacco nicotine use in the setting of THA [<xref rid="bib1" ref-type="bibr">1</xref>,<xref rid="bib4" ref-type="bibr">4</xref>,<xref rid="bib6" ref-type="bibr">6</xref>,<xref rid="bib8" ref-type="bibr">8</xref>,<xref rid="bib20" ref-type="bibr">20</xref>]. Therefore, the objective of this study was to utilize a large database to perform a propensity score-matched cohort analysis comparing the perioperative complications and rates of revision surgery between patients with NTND and those without nicotine dependence undergoing primary THA.</p></sec><sec id="sec2"><title>Material and methods</title><sec id="sec2.1"><title>Study design</title><p id="p0025">The TriNetX United States Collaborative Network (Cambridge, Massachusetts) was used to perform a retrospective cohort study of aggregated and deidentified data collected from more than 118 million patients and 68 health-care organizations [<xref rid="bib25" ref-type="bibr">25</xref>]. The platform incorporates biomedical and clinical research data from both insured and uninsured patients from a variety of organizations including hospitals, primary and specialty care centers. Access to clinical data including demographics, diagnoses, procedures, medications, laboratory values, and genomic information facilitates analysis of complex data sets [<xref rid="bib26" ref-type="bibr">26</xref>]. Institutional review board approval was not required for this study as TriNetX follows the Health Insurance Portability and Accountability Act and General Data Protection Regulation guidelines for deidentification.</p></sec><sec id="sec2.2"><title>Study population</title><p id="p0030">The United States Collaborative Network was queried on February 10, 2025, identifying all patients aged 18 and older who underwent THA between January 1, 2004, and January 1, 2024. Patients were identified using Current Procedural Terminology codes. Exclusions and patient comorbidities were determined using International Classification of Disease, 10th Revision (ICD-10) codes (<xref rid="appsec1" ref-type="sec">Supplementary Table 1</xref>). Patients with prior history of rheumatoid arthritis, femoral acetabular impingement, post-traumatic osteoarthritis, and hip dysplasia were excluded. Patients with a history of tobacco use were also excluded. Patients were then stratified into 2 cohorts based on nicotine use: nontobacco nicotine dependence and those without a preoperative diagnosis of nicotine dependence. The NTND cohort included patients with a dependence to nicotine (ICD10:F17), while excluding patients with nicotine dependence to cigarettes (ICD10:F17.21), chewing tobacco (ICD10:F17.22), and other tobacco products (ICD10:F17.29). The control group had no documented history of nicotine dependence. Propensity score matching was performed using a greedy nearest neighbor matching algorithm with a caliper of 0.1 pooled standard deviations, accounting for variables including age, gender, race, ethnicity, body mass index, type 2 diabetes mellitus, congestive heart failure, coronary artery disease, chronic kidney disease, liver disease, alcohol abuse, opioid abuse, anxiety and depression.</p><p id="p0035">A total of 99,496,579 patients aged 18 and older were identified, of which 192,826 underwent primary THA (<xref rid="fig1" ref-type="fig">Fig. 1</xref>). A total of 174,071 patients remained after excluding for history of rheumatoid arthritis, femoral acetabular impingement, post-traumatic osteoarthritis, and hip dysplasia. After exclusions for tobacco use, 154,147 patients remained. The cohorts were then stratified into NTND and those without a preoperative diagnosis of nicotine dependence. Overall, 124,013 patients met the inclusion criteria. Among these, 115,561 (93.2%) were non-nicotine users and 8452 (6.8%) were NTND patients. Significant differences between the cohorts were noted for the following variables: age, gender, race, ethnicity, body mass index, type 2 diabetes mellitus, congestive heart failure, coronary artery disease, chronic kidney disease, liver disease, alcohol abuse, opioid abuse, anxiety and depression (<xref rid="tbl1" ref-type="table">Table 1</xref>). After 1:1 propensity score matching, each cohort included 8378 patients. Significant differences were noted only for age (60.8 &#177; 11.6 vs 60.1 &#177; 12.8; <italic toggle="yes">P</italic> = .0002). Numerous medical and surgical complications were compared between cohorts at 90 days, 1 year, and 5 years postoperatively (<xref rid="tbl2" ref-type="table">Table 2</xref>, <xref rid="tbl3" ref-type="table">Table 3</xref>, <xref rid="tbl4" ref-type="table">Table 4</xref>).<fig id="fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Strengthening the Reporting of Observational Studies in Epidemiology diagram depicting the patient selection process. FAI, femoral acetabular impingement; RA, rheumatoid arthritis; OA, osteoarthritis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig><table-wrap position="float" id="tbl1" orientation="portrait"><label>Table 1</label><caption><p>Baseline demographics and comorbidities before and after 1:1 propensity matching.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Demographics and comorbidities</th><th colspan="3" rowspan="1">Before matching<hr/></th><th colspan="3" rowspan="1">After matching<hr/></th></tr><tr><th colspan="1" rowspan="1">NTND (n = 8452)</th><th colspan="1" rowspan="1">Control (n = 115,561)</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th><th colspan="1" rowspan="1">NTND (n = 8378)</th><th colspan="1" rowspan="1">Control (n = 8378)</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="7" rowspan="1">Demographics</td></tr><tr><td colspan="1" rowspan="1">&#160;Age</td><td colspan="1" rowspan="1">60.8 &#177; 11.6</td><td colspan="1" rowspan="1">65.7 &#177; 11.5</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td colspan="1" rowspan="1">60.8 &#177; 11.6</td><td colspan="1" rowspan="1">60.1 &#177; 12.8</td><td align="char" colspan="1" rowspan="1"><bold>.0002</bold></td></tr><tr><td colspan="1" rowspan="1">&#160;Male</td><td align="char" colspan="1" rowspan="1">4424 (52.7)</td><td align="char" colspan="1" rowspan="1">48,363 (42.1)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">4408 (52.6)</td><td align="char" colspan="1" rowspan="1">4417 (52.7)</td><td align="char" colspan="1" rowspan="1">.889</td></tr><tr><td colspan="1" rowspan="1">&#160;Female</td><td align="char" colspan="1" rowspan="1">3711 (44.2)</td><td align="char" colspan="1" rowspan="1">61,394 (53.4)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">3706 (44.2)</td><td align="char" colspan="1" rowspan="1">3712 (44.3)</td><td align="char" colspan="1" rowspan="1">.926</td></tr><tr><td colspan="1" rowspan="1">&#160;Body Mass Index(kg/m<sup>2</sup>)</td><td colspan="1" rowspan="1">30.2 &#177; 6.3</td><td colspan="1" rowspan="1">29.9 &#177; 6.0</td><td align="char" colspan="1" rowspan="1">.003</td><td colspan="1" rowspan="1">30.2 &#177; 6.3</td><td colspan="1" rowspan="1">30.3 &#177; 6.2</td><td align="char" colspan="1" rowspan="1">.653</td></tr><tr><td colspan="1" rowspan="1">&#160;&lt;18.5</td><td align="char" colspan="1" rowspan="1">239 (2.8)</td><td align="char" colspan="1" rowspan="1">1698 (1.5)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">236 (2.8)</td><td align="char" colspan="1" rowspan="1">224 (2.7)</td><td align="char" colspan="1" rowspan="1">.57</td></tr><tr><td colspan="1" rowspan="1">&#160;18.5-25</td><td align="char" colspan="1" rowspan="1">1819 (21.7)</td><td align="char" colspan="1" rowspan="1">21,841 (19.0)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">1810 (21.6)</td><td align="char" colspan="1" rowspan="1">1709 (20.4)</td><td align="char" colspan="1" rowspan="1">.055</td></tr><tr><td colspan="1" rowspan="1">&#160;25-30</td><td align="char" colspan="1" rowspan="1">3006 (35.8)</td><td align="char" colspan="1" rowspan="1">37,450 (32.6)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">2995 (35.7)</td><td align="char" colspan="1" rowspan="1">2925 (34.9)</td><td align="char" colspan="1" rowspan="1">.258</td></tr><tr><td colspan="1" rowspan="1">&#160;30-35</td><td align="char" colspan="1" rowspan="1">2641 (31.4)</td><td align="char" colspan="1" rowspan="1">31,316 (27.2)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">2632 (31.4)</td><td align="char" colspan="1" rowspan="1">2556 (30.5)</td><td align="char" colspan="1" rowspan="1">.204</td></tr><tr><td colspan="1" rowspan="1">&#160;35-40</td><td align="char" colspan="1" rowspan="1">1508 (18.0)</td><td align="char" colspan="1" rowspan="1">17,934 (15.6)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">1504 (18.0)</td><td align="char" colspan="1" rowspan="1">1491 (17.8)</td><td align="char" colspan="1" rowspan="1">.793</td></tr><tr><td colspan="1" rowspan="1">&#160;&gt;40</td><td align="char" colspan="1" rowspan="1">820 (9.8)</td><td align="char" colspan="1" rowspan="1">9147 (8.0)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">817 (9.8)</td><td align="char" colspan="1" rowspan="1">817 (9.8)</td><td align="char" colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">&#160;White</td><td align="char" colspan="1" rowspan="1">6295 (74.9)</td><td align="char" colspan="1" rowspan="1">90,549 (78.8)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">6282 (75.0)</td><td align="char" colspan="1" rowspan="1">6302 (75.2)</td><td align="char" colspan="1" rowspan="1">.721</td></tr><tr><td colspan="1" rowspan="1">&#160;Black or African American</td><td align="char" colspan="1" rowspan="1">1171 (13.9)</td><td align="char" colspan="1" rowspan="1">9180 (8.0)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">1166 (13.9)</td><td align="char" colspan="1" rowspan="1">1191 (14.2)</td><td align="char" colspan="1" rowspan="1">.579</td></tr><tr><td colspan="1" rowspan="1">&#160;Hispanic or Latino</td><td align="char" colspan="1" rowspan="1">221 (2.6)</td><td align="char" colspan="1" rowspan="1">3188 (2.8)</td><td align="char" colspan="1" rowspan="1">.442</td><td align="char" colspan="1" rowspan="1">221 (2.6)</td><td align="char" colspan="1" rowspan="1">206 (2.5)</td><td align="char" colspan="1" rowspan="1">.462</td></tr><tr><td colspan="1" rowspan="1">&#160;Asian</td><td align="char" colspan="1" rowspan="1">108 (1.3)</td><td align="char" colspan="1" rowspan="1">2586 (2.2)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">108 (1.3)</td><td align="char" colspan="1" rowspan="1">104 (1.2)</td><td align="char" colspan="1" rowspan="1">.782</td></tr><tr><td colspan="1" rowspan="1">&#160;Native Hawaiian or Pacific Islander</td><td align="char" colspan="1" rowspan="1">46 (0.5)</td><td align="char" colspan="1" rowspan="1">444 (0.4)</td><td align="char" colspan="1" rowspan="1">.023</td><td align="char" colspan="1" rowspan="1">46 (0.5)</td><td align="char" colspan="1" rowspan="1">49 (0.6)</td><td align="char" colspan="1" rowspan="1">.758</td></tr><tr><td colspan="1" rowspan="1">&#160;American Indian or Alaska Native</td><td align="char" colspan="1" rowspan="1">20 (0.2)</td><td align="char" colspan="1" rowspan="1">187 (0.2)</td><td align="char" colspan="1" rowspan="1">.103</td><td align="char" colspan="1" rowspan="1">20 (0.2)</td><td align="char" colspan="1" rowspan="1">13 (0.2)</td><td align="char" colspan="1" rowspan="1">.223</td></tr><tr><td colspan="7" rowspan="1">Comorbidities</td></tr><tr><td colspan="1" rowspan="1">&#160;Type 2 Diabetes Mellitus</td><td align="char" colspan="1" rowspan="1">1411 (16.8)</td><td align="char" colspan="1" rowspan="1">12,672 (11.0)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">1402 (16.7)</td><td align="char" colspan="1" rowspan="1">1346 (16.1)</td><td align="char" colspan="1" rowspan="1">.243</td></tr><tr><td colspan="1" rowspan="1">&#160;Congestive Heart Failure</td><td align="char" colspan="1" rowspan="1">714 (8.5)</td><td align="char" colspan="1" rowspan="1">4830 (4.2)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">703 (8.4)</td><td align="char" colspan="1" rowspan="1">654 (7.8)</td><td align="char" colspan="1" rowspan="1">.165</td></tr><tr><td colspan="1" rowspan="1">&#160;Coronary Artery Disease</td><td align="char" colspan="1" rowspan="1">1424 (17.0)</td><td align="char" colspan="1" rowspan="1">10,886 (9.5)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">1410 (16.8)</td><td align="char" colspan="1" rowspan="1">1325 (15.8)</td><td align="char" colspan="1" rowspan="1">.076</td></tr><tr><td colspan="1" rowspan="1">&#160;Chronic Kidney Disease</td><td align="char" colspan="1" rowspan="1">766 (9.1)</td><td align="char" colspan="1" rowspan="1">7841 (6.8)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">761 (9.1)</td><td align="char" colspan="1" rowspan="1">721 (8.6)</td><td align="char" colspan="1" rowspan="1">.276</td></tr><tr><td colspan="1" rowspan="1">&#160;Liver Disease</td><td align="char" colspan="1" rowspan="1">167 (2.0)</td><td align="char" colspan="1" rowspan="1">1279 (1.1)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">164 (2.0)</td><td align="char" colspan="1" rowspan="1">154 (1.8)</td><td align="char" colspan="1" rowspan="1">.571</td></tr><tr><td colspan="1" rowspan="1">&#160;Alcohol Abuse</td><td align="char" colspan="1" rowspan="1">1036 (12.3)</td><td align="char" colspan="1" rowspan="1">2608 (2.3)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">1016 (12.1)</td><td align="char" colspan="1" rowspan="1">937 (11.2)</td><td align="char" colspan="1" rowspan="1">.057</td></tr><tr><td colspan="1" rowspan="1">&#160;Opioid Abuse</td><td align="char" colspan="1" rowspan="1">103 (1.2)</td><td align="char" colspan="1" rowspan="1">193 (0.2)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">93 (1.1)</td><td align="char" colspan="1" rowspan="1">70 (0.8)</td><td align="char" colspan="1" rowspan="1">.07</td></tr><tr><td colspan="1" rowspan="1">&#160;Anxiety</td><td align="char" colspan="1" rowspan="1">1785 (21.3)</td><td align="char" colspan="1" rowspan="1">13,192 (11.5)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">1767 (21.1)</td><td align="char" colspan="1" rowspan="1">1758 (21.0)</td><td align="char" colspan="1" rowspan="1">.865</td></tr><tr><td colspan="1" rowspan="1">&#160;Depression</td><td align="char" colspan="1" rowspan="1">743 (8.8)</td><td align="char" colspan="1" rowspan="1">6027 (5.2)</td><td align="char" colspan="1" rowspan="1">&lt;.001</td><td align="char" colspan="1" rowspan="1">739 (8.8)</td><td align="char" colspan="1" rowspan="1">708 (8.5)</td><td align="char" colspan="1" rowspan="1">.394</td></tr></tbody></table><table-wrap-foot><fn id="tspara0015"><p>All data are presented as mean &#177; standard deviation or n (%) unless otherwise specified.</p></fn><fn id="tspara0020"><p>Bolded <italic toggle="yes">P</italic> values indicate statistical significance (<italic toggle="yes">P</italic> &lt; .05).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tbl2" orientation="portrait"><label>Table 2</label><caption><p>Early 90-day postoperative complications in patients aged 18 and older undergoing THA with and without NTND.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Complication</th><th colspan="1" rowspan="1">NTND (n = 8378)</th><th colspan="1" rowspan="1">Control (n = 8378)</th><th colspan="1" rowspan="1">OR (95% CI)</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">DVT</td><td align="char" colspan="1" rowspan="1">123 (1.47)</td><td align="char" colspan="1" rowspan="1">117 (1.40)</td><td align="char" colspan="1" rowspan="1">1.052 (0.815-1.358)</td><td align="char" colspan="1" rowspan="1">.696</td></tr><tr><td colspan="1" rowspan="1">PE</td><td align="char" colspan="1" rowspan="1">81 (0.97)</td><td align="char" colspan="1" rowspan="1">76 (0.91)</td><td align="char" colspan="1" rowspan="1">1.066 (0.779-1.461)</td><td align="char" colspan="1" rowspan="1">.688</td></tr><tr><td colspan="1" rowspan="1">MI</td><td align="char" colspan="1" rowspan="1">76 (0.91)</td><td align="char" colspan="1" rowspan="1">39 (0.47)</td><td align="char" colspan="1" rowspan="1">1.957 (1.329-2.883)</td><td align="char" colspan="1" rowspan="1"><bold>.001</bold></td></tr><tr><td colspan="1" rowspan="1">Stroke</td><td align="char" colspan="1" rowspan="1">88 (1.05)</td><td align="char" colspan="1" rowspan="1">48 (0.57)</td><td align="char" colspan="1" rowspan="1">1.842 (1.294-2.622)</td><td align="char" colspan="1" rowspan="1"><bold>.001</bold></td></tr><tr><td colspan="1" rowspan="1">Pneumonia</td><td align="char" colspan="1" rowspan="1">168 (2.01)</td><td align="char" colspan="1" rowspan="1">73 (0.87)</td><td align="char" colspan="1" rowspan="1">2.328 (1.766-3.069)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">AKI</td><td align="char" colspan="1" rowspan="1">215 (2.57)</td><td align="char" colspan="1" rowspan="1">162 (1.93)</td><td align="char" colspan="1" rowspan="1">1.336 (1.087-1.642)</td><td align="char" colspan="1" rowspan="1"><bold>.006</bold></td></tr><tr><td colspan="1" rowspan="1">Sepsis</td><td align="char" colspan="1" rowspan="1">83 (0.99)</td><td align="char" colspan="1" rowspan="1">50 (0.60)</td><td align="char" colspan="1" rowspan="1">1.667 (1.172-2.370)</td><td align="char" colspan="1" rowspan="1"><bold>.0041</bold></td></tr><tr><td colspan="1" rowspan="1">Wound Dehiscence</td><td align="char" colspan="1" rowspan="1">25 (0.30)</td><td align="char" colspan="1" rowspan="1">14 (0.17)</td><td align="char" colspan="1" rowspan="1">1.788 (0.929-3.442)</td><td align="char" colspan="1" rowspan="1">.078</td></tr><tr><td colspan="1" rowspan="1">Infection</td><td align="char" colspan="1" rowspan="1">108 (1.29)</td><td align="char" colspan="1" rowspan="1">89 (1.06)</td><td align="char" colspan="1" rowspan="1">1.216 (0.917-1.613)</td><td align="char" colspan="1" rowspan="1">.173</td></tr><tr><td colspan="1" rowspan="1">ED Visit</td><td align="char" colspan="1" rowspan="1">749 (8.94)</td><td align="char" colspan="1" rowspan="1">577 (6.89)</td><td align="char" colspan="1" rowspan="1">1.327 (1.185-1.486)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">Rehospitalization</td><td align="char" colspan="1" rowspan="1">843 (10.06)</td><td align="char" colspan="1" rowspan="1">585 (6.98)</td><td align="char" colspan="1" rowspan="1">1.490 (1.335-1.664)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">Death</td><td align="char" colspan="1" rowspan="1">55 (0.66)</td><td align="char" colspan="1" rowspan="1">35 (0.42)</td><td align="char" colspan="1" rowspan="1">1.575 (1.030-2.409)</td><td align="char" colspan="1" rowspan="1"><bold>.035</bold></td></tr><tr><td colspan="1" rowspan="1">PJI</td><td align="char" colspan="1" rowspan="1">133 (1.59)</td><td align="char" colspan="1" rowspan="1">90 (1.07)</td><td align="char" colspan="1" rowspan="1">1.485 (1.135-1.944)</td><td align="char" colspan="1" rowspan="1"><bold>.004</bold></td></tr><tr><td colspan="1" rowspan="1">Mechanical Loosening</td><td align="char" colspan="1" rowspan="1">10 (0.12)</td><td align="char" colspan="1" rowspan="1">10 (0.12)</td><td align="char" colspan="1" rowspan="1">1.000 (0.416-2.404)</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Periprosthetic Hip Dislocation</td><td align="char" colspan="1" rowspan="1">43 (0.51)</td><td align="char" colspan="1" rowspan="1">32 (0.38)</td><td align="char" colspan="1" rowspan="1">1.346 (0.851-2.128)</td><td align="char" colspan="1" rowspan="1">.203</td></tr><tr><td colspan="1" rowspan="1">Periprosthetic Hip Fracture</td><td align="char" colspan="1" rowspan="1">35 (0.42)</td><td align="char" colspan="1" rowspan="1">44 (0.53)</td><td align="char" colspan="1" rowspan="1">0.795 (0.509-1.240)</td><td align="char" colspan="1" rowspan="1">.31</td></tr><tr><td colspan="1" rowspan="1">Revision THA</td><td align="char" colspan="1" rowspan="1">67 (0.80)</td><td align="char" colspan="1" rowspan="1">36 (0.43)</td><td align="char" colspan="1" rowspan="1">1.868 (1.244-2.804)</td><td align="char" colspan="1" rowspan="1"><bold>.002</bold></td></tr></tbody></table><table-wrap-foot><fn id="tspara0030"><p>PE, pulmonary embolism.</p></fn><fn id="tspara0035"><p>All data are presented as n (%) unless otherwise specified.</p></fn><fn id="tspara0040"><p>Bolded <italic toggle="yes">P</italic> values indicate statistical significance (<italic toggle="yes">P</italic> &lt; .05).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tbl3" orientation="portrait"><label>Table 3</label><caption><p>Delayed 1-year postoperative complications in patients aged 18 and older undergoing THA with and without NTND.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Complication</th><th colspan="1" rowspan="1">NTND (n = 8378)</th><th colspan="1" rowspan="1">Control (n = 8378)</th><th colspan="1" rowspan="1">OR (95% CI)</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">DVT</td><td align="char" colspan="1" rowspan="1">198 (2.36)</td><td align="char" colspan="1" rowspan="1">159 (1.90)</td><td align="char" colspan="1" rowspan="1">1.251 (1.013-1.545)</td><td align="char" colspan="1" rowspan="1"><bold>.0369</bold></td></tr><tr><td colspan="1" rowspan="1">PE</td><td align="char" colspan="1" rowspan="1">130 (1.55)</td><td align="char" colspan="1" rowspan="1">117 (1.40)</td><td align="char" colspan="1" rowspan="1">1.113 (0.856-1.431)</td><td align="char" colspan="1" rowspan="1">.405</td></tr><tr><td colspan="1" rowspan="1">MI</td><td align="char" colspan="1" rowspan="1">148 (1.77)</td><td align="char" colspan="1" rowspan="1">90 (1.07)</td><td align="char" colspan="1" rowspan="1">1.656 (1.272-2.156)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">Stroke</td><td align="char" colspan="1" rowspan="1">169 (2.02)</td><td align="char" colspan="1" rowspan="1">124 (1.48)</td><td align="char" colspan="1" rowspan="1">1.370 (1.085-1.731)</td><td align="char" colspan="1" rowspan="1"><bold>.008</bold></td></tr><tr><td colspan="1" rowspan="1">Pneumonia</td><td align="char" colspan="1" rowspan="1">348 (4.15)</td><td align="char" colspan="1" rowspan="1">168 (2.01)</td><td align="char" colspan="1" rowspan="1">2.118 (1.757-2.553)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">AKI</td><td align="char" colspan="1" rowspan="1">391 (4.67)</td><td align="char" colspan="1" rowspan="1">285 (3.40)</td><td align="char" colspan="1" rowspan="1">1.390 (1.190-1.624)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">Sepsis</td><td align="char" colspan="1" rowspan="1">162 (1.93)</td><td align="char" colspan="1" rowspan="1">112 (1.34)</td><td align="char" colspan="1" rowspan="1">1.455 (1.142-1.855)</td><td align="char" colspan="1" rowspan="1"><bold>.0023</bold></td></tr><tr><td colspan="1" rowspan="1">Infection</td><td align="char" colspan="1" rowspan="1">145 (1.73)</td><td align="char" colspan="1" rowspan="1">113 (1.35)</td><td align="char" colspan="1" rowspan="1">1.288 (1.005-1.650)</td><td align="char" colspan="1" rowspan="1"><bold>.0447</bold></td></tr><tr><td colspan="1" rowspan="1">ED Visit</td><td align="char" colspan="1" rowspan="1">1466 (17.50)</td><td align="char" colspan="1" rowspan="1">1120 (13.37)</td><td align="char" colspan="1" rowspan="1">1.374 (1.263-1.496)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">Rehospitalization</td><td align="char" colspan="1" rowspan="1">1208 (14.42)</td><td align="char" colspan="1" rowspan="1">873 (10.42)</td><td align="char" colspan="1" rowspan="1">1.448 (1.320-1.589)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">Death</td><td align="char" colspan="1" rowspan="1">186 (2.22)</td><td align="char" colspan="1" rowspan="1">88 (1.05)</td><td align="char" colspan="1" rowspan="1">2.139 (1.657-2.761)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">PJI</td><td align="char" colspan="1" rowspan="1">175 (2.09)</td><td align="char" colspan="1" rowspan="1">127 (1.52)</td><td align="char" colspan="1" rowspan="1">1.386 (1.101-1.745)</td><td align="char" colspan="1" rowspan="1"><bold>.005</bold></td></tr><tr><td colspan="1" rowspan="1">Mechanical Loosening</td><td align="char" colspan="1" rowspan="1">18 (0.21)</td><td align="char" colspan="1" rowspan="1">14 (0.17)</td><td align="char" colspan="1" rowspan="1">1.286 (0.639-2.588)</td><td align="char" colspan="1" rowspan="1">.479</td></tr><tr><td colspan="1" rowspan="1">Periprosthetic Hip Dislocation</td><td align="char" colspan="1" rowspan="1">60 (0.72)</td><td align="char" colspan="1" rowspan="1">56 (0.67)</td><td align="char" colspan="1" rowspan="1">1.072 (0.744-1.545)</td><td align="char" colspan="1" rowspan="1">.709</td></tr><tr><td colspan="1" rowspan="1">Periprosthetic Hip Fracture</td><td align="char" colspan="1" rowspan="1">52 (0.62)</td><td align="char" colspan="1" rowspan="1">56 (0.67)</td><td align="char" colspan="1" rowspan="1">0.928 (0.636-1.355)</td><td align="char" colspan="1" rowspan="1">.699</td></tr><tr><td colspan="1" rowspan="1">Revision THA</td><td align="char" colspan="1" rowspan="1">169 (2.02)</td><td align="char" colspan="1" rowspan="1">116 (1.38)</td><td align="char" colspan="1" rowspan="1">1.466 (1.155-1.861)</td><td align="char" colspan="1" rowspan="1"><bold>.0015</bold></td></tr></tbody></table><table-wrap-foot><fn id="tspara0050"><p>PE, pulmonary embolism.</p></fn><fn id="tspara0055"><p>All data are presented as n (%) unless otherwise specified.</p></fn><fn id="tspara0060"><p>Bolded <italic toggle="yes">P</italic> values indicate statistical significance (<italic toggle="yes">P</italic> &lt; .05).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tbl4" orientation="portrait"><label>Table 4</label><caption><p>Delayed 5-year postoperative complications in patients aged 18 and older undergoing THA with and without NTND.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Complication</th><th colspan="1" rowspan="1">NTND (n = 8378)</th><th colspan="1" rowspan="1">Control (n = 8378)</th><th colspan="1" rowspan="1">OR (95% CI)</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Death</td><td align="char" colspan="1" rowspan="1">654 (7.81)</td><td align="char" colspan="1" rowspan="1">322 (3.84)</td><td align="char" colspan="1" rowspan="1">2.118 (1.847-2.429)</td><td align="char" colspan="1" rowspan="1"><bold>&lt;.0001</bold></td></tr><tr><td colspan="1" rowspan="1">PJI</td><td align="char" colspan="1" rowspan="1">250 (2.98)</td><td align="char" colspan="1" rowspan="1">179 (2.14)</td><td align="char" colspan="1" rowspan="1">1.409 (1.160-1.711)</td><td align="char" colspan="1" rowspan="1"><bold>.001</bold></td></tr><tr><td colspan="1" rowspan="1">Mechanical Loosening</td><td align="char" colspan="1" rowspan="1">38 (0.45)</td><td align="char" colspan="1" rowspan="1">40 (0.48)</td><td align="char" colspan="1" rowspan="1">0.950 (0.609-1.482)</td><td align="char" colspan="1" rowspan="1">.82</td></tr><tr><td colspan="1" rowspan="1">Periprosthetic Hip Dislocation</td><td align="char" colspan="1" rowspan="1">102 (1.22)</td><td align="char" colspan="1" rowspan="1">95 (1.13)</td><td align="char" colspan="1" rowspan="1">1.075 (0.811-1.423)</td><td align="char" colspan="1" rowspan="1">.616</td></tr><tr><td colspan="1" rowspan="1">Periprosthetic Hip Fracture</td><td align="char" colspan="1" rowspan="1">85 (1.01)</td><td align="char" colspan="1" rowspan="1">86 (1.03)</td><td align="char" colspan="1" rowspan="1">0.988 (0.731-1.336)</td><td align="char" colspan="1" rowspan="1">.939</td></tr><tr><td colspan="1" rowspan="1">Revision THA</td><td align="char" colspan="1" rowspan="1">270 (3.22)</td><td align="char" colspan="1" rowspan="1">212 (2.53)</td><td align="char" colspan="1" rowspan="1">1.283 (1.069-1.540)</td><td align="char" colspan="1" rowspan="1"><bold>.0073</bold></td></tr></tbody></table><table-wrap-foot><fn id="tspara0070"><p>All data are presented as n (%) unless otherwise specified.</p></fn><fn id="tspara0075"><p>Bolded <italic toggle="yes">P</italic> values indicate statistical significance (<italic toggle="yes">P</italic> &lt; .05).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec2.3"><title>Data collection and outcomes</title><p id="p0040">THA was indicated as the index event. Patient cohorts were assessed for demographics including age, race, ethnicity, and sex. All outcomes were analyzed at 90 days and 1 year after surgery. Rates of mechanical loosening, periprosthetic hip dislocation, periprosthetic hip fracture, PJI, revision THA, and mortality were analyzed 5 years postoperatively for patients with the allotted postoperative follow-up time since primary THA. The primary outcome in this study was revision THA at 1 year. Our secondary objective was to assess the relationship between patients with NTND and the following postoperative medical and surgical complications, including DVT, pulmonary embolism, myocardial infarction (MI), stroke, pneumonia, acute kidney injury (AKI), sepsis, wound dehiscence, postoperative infection, emergency department (ED) visits, rehospitalizations, mortality, PJI, mechanical loosening, periprosthetic hip dislocation, and periprosthetic hip fracture. These outcomes were identified by ICD-10 codes (<xref rid="appsec1" ref-type="sec">Supplementary Table 1</xref>).</p></sec><sec id="sec2.4"><title>Data analysis</title><p id="p0045">The TriNetX platform was utilized for all statistical analyses using built-in statistical tools. Descriptive statistics were calculated for all continuous and categorical variables. Continuous variables were reported as mean &#177; standard deviation whereas categorical variables were reported as frequencies with percentages. A chi-squared (&#967;<sup>2</sup>) test was used to analyze categorical variables, and an independent samples t-test was used to analyze the difference in means for continuous variables. A <italic toggle="yes">P</italic> value &#8805;.05 was considered statistically significant.</p></sec></sec><sec id="sec3"><title>Results</title><sec id="sec3.1"><title>Early postoperative complications</title><p id="p0050">Postoperative complications were evaluated at 90 days and compared between NTND patients and those without a prior history of nicotine dependence. (<xref rid="tbl2" ref-type="table">Table 2</xref>). Overall, complications including MI (OR 1.656, 95% confidence interval (CI) 1.272-2.156; <italic toggle="yes">P</italic> &lt; .0001), stroke (OR 1.370, 95% CI 1.085-1.731; <italic toggle="yes">P</italic> = .008), pneumonia (OR 2.118, 95% CI 1.757-2.553; <italic toggle="yes">P</italic> &lt; .0001), AKI (OR 1.390, 95% CI 1.190-1.624; <italic toggle="yes">P</italic> &lt; .0001), sepsis (OR 1.455, 95% CI 1.142-1.855; <italic toggle="yes">P</italic> = .0023), PJI (OR 1.485, 95% CI 1.135-1.944; <italic toggle="yes">P</italic> = .004), and death (OR 1.575, 95% CI 1.030-2.409; <italic toggle="yes">P</italic> = .035) were significantly higher in NTND patients. NTND patients also had a significantly increased rates of ED visits (OR 1.327, 95% CI 1.185-1.486; <italic toggle="yes">P</italic> &lt; .0001), rehospitalization (OR 1.490, 95% CI 1.335-1.664; <italic toggle="yes">P</italic> &lt; .0001) and revision THA at 90 days (OR 1.868, 95% CI 1.244-2.804; <italic toggle="yes">P</italic> = .002).</p></sec><sec id="sec3.2"><title>Delayed postoperative complications</title><p id="p0055">Among patients with and without NTND, delayed complications were compared between cohorts from 1 year and 5 years postoperatively (<xref rid="tbl3" ref-type="table">Table 3</xref>, <xref rid="tbl4" ref-type="table">Table 4</xref>). Notably, the rate of revision THA was significantly elevated in the NTND cohort (OR 1.466, 95% CI 1.155-1.861; <italic toggle="yes">P</italic> = .0015). Medical events such as DVT (OR 1.251, 95% CI 1.013-1.545; <italic toggle="yes">P</italic> = .0369), MI (OR 1.957, 95% CI 1.329-2.883; <italic toggle="yes">P</italic> = .001), stroke (OR 1.842, 95% CI 1.294-2.622; <italic toggle="yes">P</italic> = .001), pneumonia (OR 2.328, 95% CI 1.766-3.069; <italic toggle="yes">P</italic> &lt; .0001), AKI (OR 1.336, 95% CI 1.087-1.642; <italic toggle="yes">P</italic> = .006), sepsis (OR 1.667, 95% CI 1.172-2.370; <italic toggle="yes">P</italic> = .0041), postoperative infection (OR 1.288, 95% CI 1.005-1.650; <italic toggle="yes">P</italic> = .045), ED visits (OR 1.374, 95% CI 1.263-1.496; <italic toggle="yes">P</italic> &lt; .0001), and rehospitalization (OR 1.448, 95% CI 1.320-1.589; <italic toggle="yes">P</italic> &lt; .0001) were significantly higher 1 year postoperatively in NTND patients (<xref rid="tbl3" ref-type="table">Table 3</xref>). Furthermore, rates of PJI (OR 1.386, 95% CI 1.101-1.745; <italic toggle="yes">P</italic> = .005) and death (OR 2.139, 95% CI 1.657-2.761; <italic toggle="yes">P</italic> &lt; .0001) remained significantly elevated in NTND patients compared to their counterparts.</p><p id="p0060">At 5 years postoperatively, rates of PJI (OR 1.409, 95% CI 1.160-1.711; <italic toggle="yes">P</italic> = .001), all cause revision THA (OR 1.283, 95% CI 1.069-1.540; <italic toggle="yes">P</italic> = .0073), and death (OR 2.118, 95% CI 1.847-2.429; <italic toggle="yes">P</italic> &lt; .0001) also remained significantly higher in the NTND cohort (<xref rid="tbl4" ref-type="table">Table 4</xref>). However, no significant differences were appreciated between cohorts among rates of mechanical loosening (OR 0.950, 95% CI 0.609-1.482; <italic toggle="yes">P</italic> = .82), periprosthetic hip dislocation (OR 1.075, 95% CI 0.811-1.423; <italic toggle="yes">P</italic> = .616), and periprosthetic hip fracture (OR 0.988, 95% CI 0.731-1.336; <italic toggle="yes">P</italic> = .939).</p></sec></sec><sec id="sec4"><title>Discussion</title><p id="p0065">To our knowledge, this is the first study investigating the association between NTND and postoperative complications and rates of revision surgery after THA. Our results demonstrate that NTND patients are at an elevated risk for numerous postoperative complications including DVT, MI, stroke, pneumonia, AKI, sepsis, PJI, infection, ED visits, rehospitalization, and mortality up to 5 years postoperatively. Furthermore, patients with NTND also underwent revision THA at higher rates compared to those without a history of nicotine dependence.</p><p id="p0070">Our NTND cohort demonstrated an increased risk for numerous infectious complications including postoperative wound infection, pneumonia, sepsis, and PJI, similar to results of other studies examining effects of traditional tobacco use in THA and TKA [<xref rid="bib3" ref-type="bibr">3</xref>,<xref rid="bib9" ref-type="bibr">9</xref>,<xref rid="bib27" ref-type="bibr">27</xref>]. These results are further supported from studies in NTND patients undergoing anterior cervical discectomy and fusion, TKA, and total shoulder arthroplasty (TSA) [<xref rid="bib3" ref-type="bibr">3</xref>,<xref rid="bib9" ref-type="bibr">9</xref>,<xref rid="bib24" ref-type="bibr">24</xref>,<xref rid="bib27" ref-type="bibr">[27]</xref>, <xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>]. Our results support that PJI and other infectious complications in NTND patients undergoing THA seem to mirror those of traditional tobacco users. In addition to immune dysregulation and postoperative infection susceptibility, nicotine is responsible for numerous other effects including tissue hypoperfusion, epithelial dysfunction, and free radical production [<xref rid="bib21" ref-type="bibr">[21]</xref>, <xref rid="bib22" ref-type="bibr">[22]</xref>, <xref rid="bib23" ref-type="bibr">[23]</xref>]. The NTND cohort in our study demonstrated higher rates for MI and stroke at 90 days following THA. Furthermore, the risks of DVT, MI, and stroke persisted at 1 year postoperatively. In contrast to pure nicotine products, these vascular complications and systemic effects of traditional tobacco use are well known, particularly relating to complications for patients undergoing THA [<xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib6" ref-type="bibr">[6]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>,<xref rid="bib30" ref-type="bibr">30</xref>,<xref rid="bib31" ref-type="bibr">31</xref>]. The results of the presents study are corroborated by prior research substantiating negative outcomes in orthopaedic patients with NTND [<xref rid="bib24" ref-type="bibr">24</xref>,<xref rid="bib28" ref-type="bibr">28</xref>,<xref rid="bib29" ref-type="bibr">29</xref>]. Patients undergoing TKA have increased rates of DVT and pulmonary embolism, while patients undergoing TSA exhibited higher rates of MI and stroke [<xref rid="bib24" ref-type="bibr">24</xref>,<xref rid="bib29" ref-type="bibr">29</xref>]. These findings collectively highlight the need for increased preoperative strategies to mitigate the risk of NTND.</p><p id="p0075">Our study is the first to analyze the relationship between NTND and mortality for patients undergoing various surgical interventions. We determined patients with NTND had increased risk for mortality at all postoperative time points compared to non-nicotine users. The 90 day mortality rates from this study were slightly higher to alternative studies in primary THA [<xref rid="bib32" ref-type="bibr">32</xref>,<xref rid="bib33" ref-type="bibr">33</xref>]. These results are supported by the existing body of literature investigating cigarette smokers [<xref rid="bib3" ref-type="bibr">3</xref>,<xref rid="bib6" ref-type="bibr">6</xref>,<xref rid="bib9" ref-type="bibr">9</xref>,<xref rid="bib34" ref-type="bibr">34</xref>]. Increased rates of pre-existing comorbid conditions in tobacco and nicotine users likely predispose these patients to an increase in perioperative complications and mortality thereby explaining the increased risk of medical events at 1 year following THA.</p><p id="p0080">The present study also demonstrated increased risk for revision THA at 90 days, 1 year, and 5 years postoperatively among the NTND cohort. These results are relatively comparable to alternative studies investigating rates of revision in patients undergoing primary THA, with rates ranging between 0.6%-1.4% [<xref rid="bib6" ref-type="bibr">6</xref>,<xref rid="bib35" ref-type="bibr">35</xref>,<xref rid="bib36" ref-type="bibr">36</xref>]. A recent study by Bongers et al demonstrated rates of revision are higher for smokers than for nonsmokers in the first 2 years following THA and TKA [<xref rid="bib37" ref-type="bibr">37</xref>]. These results have been supported by alternative studies in total joint arthroplasty [<xref rid="bib6" ref-type="bibr">6</xref>,<xref rid="bib7" ref-type="bibr">7</xref>,<xref rid="bib9" ref-type="bibr">9</xref>]. DeShazo et al also demonstrated increased rates of revision TKA in NTND patients at 3 years postoperatively, further supporting these findings [<xref rid="bib24" ref-type="bibr">24</xref>].</p><p id="p0085">In contrast to our findings, Lawand et al evaluated NTND outcomes in patients undergoing TSA, observing higher rates of mechanical loosening and prosthetic joint dislocation [<xref rid="bib29" ref-type="bibr">29</xref>]. Although smoking has also been shown to increase risk for aseptic loosening following THA, the risk of dislocation did not correlate with smoking status which was similar to our findings in NTND patients [<xref rid="bib38" ref-type="bibr">38</xref>]. The current study failed to demonstrate any association between NTND and aseptic loosening. Further basic science research is needed to elucidate why smoking differed from NTND in this specific instance.</p><p id="p0090">Tobacco cessation is an important topic in the literature that has been shown to decrease infection rates following total joint arthroplasty [<xref rid="bib39" ref-type="bibr">39</xref>]. Although the American Academy of Orthopedic Surgeons recommends tobacco smoking cessation 4-6 weeks before surgical interventions, there are no formal established national arthroplasty guidelines [<xref rid="bib40" ref-type="bibr">40</xref>]. Recommendations remain informal likely due to inconsistent literature regarding the importance of specific preoperative cessation timelines [<xref rid="bib41" ref-type="bibr">41</xref>, <xref rid="bib42" ref-type="bibr">42</xref>]. Much of the current literature suggests complete cessation approximately 4 weeks before surgery, although no established guidelines exist specifically regarding nontobacco nicotine products [<xref rid="bib13" ref-type="bibr">13</xref>,<xref rid="bib41" ref-type="bibr">41</xref>,<xref rid="bib42" ref-type="bibr">42</xref>]. This highlights the need for further investigation into the appropriate preoperative cessation guideline for these patients. Given the notable morbidity and mortality risks associated with these complications, it is imperative that providers screen and provide comprehensive perioperative counseling in order to decrease complication rates. Multidisciplinary management will help optimize these patients in the perioperative setting in order to reduce complications before undergoing THA and other orthopaedic surgical interventions.</p><p id="p0095">The present study is not without limitations. The retrospective design limits its objective nature and may have resulted in selection bias. Although propensity matching was successful in generating an appropriate cohort distribution, the difference in age between cohorts may have influenced our study outcomes. Although this study attempted to achieve comprehensively propensity matched cohorts, the addition of variables may have increased the risk for a type I error. This study also utilized a large, deidentified database to collect data and perform various statistical analyses. Ultimately, this led to the inability to access individual patient records and therefore subjects the accuracy of our results to appropriate ICD-10 and Current Procedural Terminology coding. In addition, variables such as differences in nicotine delivery devices and quantitative nicotine consumption are unable to be addressed. Since the study goal to isolate patients with NTND may not have been completely precise due to inaccurate coding in patient cohort generation, the inclusion and exclusion criteria in our study design is subject to these confounding variables. Despite these limitations, the benefit of utilizing a large database was that it enabled us to perform a propensity-score matched analysis and thereby mitigate the risk of selection bias, lack of randomization, and questionable generalizability inherent in other retrospective designs.</p></sec><sec id="sec5"><title>Conclusions</title><p id="p0100">Overall, the current literature does not appropriately investigate the effects of NTND on postoperative outcomes following THA. The results of this study demonstrated that NTND is associated with an elevated rate of mortality and postoperative medical complications, including DVT, MI, stroke, pneumonia, AKI, sepsis, infection, ED visits, and rehospitalization. NTND was also associated with higher rates of PJI and revision THA compared to their counterparts up to 5 years postoperatively. The results herein serve to help surgeons counsel patients regarding postoperative risks. Further research is needed to provide further recommendations on cessation guidelines.</p></sec><sec id="sec6"><title>Conflicts of interest</title><p id="p0105">The authors declare there are no conflicts of interest.</p><p id="p0110">For full disclosure statements refer to doi: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1016/j.artd.2025.101743" id="intref0010">10.1016/j.artd.2025.101743</ext-link>.</p></sec><sec id="sec7"><title>CRediT authorship contribution statement</title><p id="p0115"><bold>Logan M. Good:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. <bold>Collin W. Blackburn:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Conceptualization. <bold>Jeremy M. Adelstein:</bold> Writing &#8211; original draft, Formal analysis, Data curation. <bold>Alexander N. Berk:</bold> Writing &#8211; original draft, Formal analysis, Conceptualization. <bold>Samuel A. Florentino:</bold> Methodology, Formal analysis. <bold>Harkirat S. Jawanda:</bold> Software, Data curation. <bold>Wayne B. Cohen-Levy:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Supervision, Resources, Funding acquisition, Conceptualization.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name name-style="western"><surname>Bojan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Perni</surname><given-names>S.</given-names></name><name name-style="western"><surname>Prokopovich</surname><given-names>P.</given-names></name></person-group><article-title>Systematic review and meta-analysis of tobacco use as a risk factor for prosthetic joint infection after total hip replacement</article-title><source>Arthroplasty Today</source><volume>6</volume><year>2020</year><fpage>959</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1016/j.artd.2020.07.011</pub-id><pub-id pub-id-type="pmid">33385034</pub-id><pub-id pub-id-type="pmcid">PMC7772455</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name name-style="western"><surname>Bedard</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>DeMik</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Owens</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Glass</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>DeBerg</surname><given-names>J.</given-names></name><name name-style="western"><surname>Callaghan</surname><given-names>J.J.</given-names></name></person-group><article-title>Tobacco use and risk of wound complications and periprosthetic joint infection: a systematic review and meta-analysis of primary total joint arthroplasty procedures</article-title><source>J Arthroplasty</source><volume>34</volume><year>2019</year><fpage>385</fpage><lpage>396.e4</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2018.09.089</pub-id><pub-id pub-id-type="pmid">30385090</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name name-style="western"><surname>Matharu</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Mouchti</surname><given-names>S.</given-names></name><name name-style="western"><surname>Twigg</surname><given-names>S.</given-names></name><name name-style="western"><surname>Delmestri</surname><given-names>A.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Judge</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pandit</surname><given-names>H.G.</given-names></name></person-group><article-title>The effect of smoking on outcomes following primary total hip and knee arthroplasty: a population-based cohort study of 117,024 patients</article-title><source>Acta Orthop</source><volume>90</volume><year>2019</year><fpage>559</fpage><lpage>567</lpage><pub-id pub-id-type="doi">10.1080/17453674.2019.1649510</pub-id><pub-id pub-id-type="pmid">31370730</pub-id><pub-id pub-id-type="pmcid">PMC6844375</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name name-style="western"><surname>Heckmann</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Katebian</surname><given-names>B.</given-names></name><name name-style="western"><surname>Chung</surname><given-names>B.C.H.</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>J.R.</given-names></name></person-group><article-title>Smoking as a risk factor for complications following total joint arthroplasty</article-title><source>Orthopedics</source><volume>44</volume><year>2021</year><fpage>e639</fpage><lpage>e644</lpage><pub-id pub-id-type="doi">10.3928/01477447-20210817-03</pub-id><pub-id pub-id-type="pmid">34590942</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name name-style="western"><surname>Duchman</surname><given-names>K.R.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Pugely</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Noiseux</surname><given-names>N.O.</given-names></name><name name-style="western"><surname>Callaghan</surname><given-names>J.J.</given-names></name></person-group><article-title>The effect of smoking on short-term complications following total hip and knee arthroplasty</article-title><source>J Bone Joint Surg Am</source><volume>97</volume><year>2015</year><fpage>1049</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.2106/JBJS.N.01016</pub-id><pub-id pub-id-type="pmid">26135071</pub-id></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Schleck</surname><given-names>C.</given-names></name><name name-style="western"><surname>Harmsen</surname><given-names>W.S.</given-names></name><name name-style="western"><surname>Jacob</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Warner</surname><given-names>D.O.</given-names></name><name name-style="western"><surname>Lewallen</surname><given-names>D.G.</given-names></name></person-group><article-title>Current tobacco use is associated with higher rates of implant revision and deep infection after total hip or knee arthroplasty: a prospective cohort study</article-title><source>BMC Med</source><volume>13</volume><year>2015</year><fpage>283</fpage><pub-id pub-id-type="doi">10.1186/s12916-015-0523-0</pub-id><pub-id pub-id-type="pmid">26586019</pub-id><pub-id pub-id-type="pmcid">PMC4653911</pub-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name name-style="western"><surname>Hagerty</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>WS</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tegethoff</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Stronach</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Keeney</surname><given-names>J.A.</given-names></name></person-group><article-title>Tobacco use is associated with more severe adverse outcomes than morbid obesity after aseptic revision TKA</article-title><source>J Knee Surg</source><volume>36</volume><year>2021</year><fpage>201</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1055/s-0041-1731459</pub-id><pub-id pub-id-type="pmid">34225364</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name name-style="western"><surname>Waters</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>L.K.</given-names></name><name name-style="western"><surname>Cole</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Springer</surname><given-names>B.D.</given-names></name><name name-style="western"><surname>Salas</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>W.F.</given-names></name></person-group><article-title>Smokeless tobacco use is associated with worse medical and surgical outcomes following total hip arthroplasty</article-title><source>J Arthroplasty</source><volume>39</volume><year>2024</year><fpage>441</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2023.05.041</pub-id><pub-id pub-id-type="pmid">37271231</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name name-style="western"><surname>Yue</surname><given-names>C.</given-names></name><name name-style="western"><surname>Cui</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Associations between smoking and clinical outcomes after total hip and knee arthroplasty: a systematic review and meta-analysis</article-title><source>Front Surg</source><volume>9</volume><year>2022</year><object-id pub-id-type="publisher-id">970537</object-id><pub-id pub-id-type="doi">10.3389/fsurg.2022.970537</pub-id><pub-id pub-id-type="pmcid">PMC9666709</pub-id><pub-id pub-id-type="pmid">36406352</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K.N.</given-names></name><name name-style="western"><surname>Park</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Do Han</surname><given-names>K.</given-names></name><name name-style="western"><surname>Han</surname><given-names>S.H.</given-names></name></person-group><article-title>The relation between cigarette smoking and development of sepsis: a 10-year follow-up study of four million adults from the national Health screening program</article-title><source>J Epidemiol Glob Health</source><volume>14</volume><year>2024</year><fpage>444</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1007/s44197-024-00197-6</pub-id><pub-id pub-id-type="pmid">38372892</pub-id><pub-id pub-id-type="pmcid">PMC11176127</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name name-style="western"><surname>Arnson</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Shoenfeld</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Amital</surname><given-names>H.</given-names></name></person-group><article-title>Effects of tobacco smoke on immunity, inflammation and autoimmunity</article-title><source>Environ Geoepidemiology Autoimmune Dis</source><volume>34</volume><year>2010</year><fpage>J258</fpage><lpage>J265</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2009.12.003</pub-id><pub-id pub-id-type="pmid">20042314</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name name-style="western"><surname>Hart</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rainer</surname><given-names>W.G.</given-names></name><name name-style="western"><surname>Taunton</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Mabry</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Berry</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Abdel</surname><given-names>M.P.</given-names></name></person-group><article-title>Cotinine testing improves smoking cessation before total joint arthroplasty</article-title><source>J Arthroplasty</source><volume>34</volume><year>2019</year><fpage>S148</fpage><lpage>S151</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2018.11.039</pub-id><pub-id pub-id-type="pmid">30579712</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name name-style="western"><surname>Jarusriwanna</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kinov</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kova&#269;</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kutty</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kyte</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lamichhane</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M.</given-names></name></person-group><article-title>Should smoking cessation Be recommended and required for patients undergoing elective knee or hip arthroplasty?</article-title><source>J Arthroplasty</source><volume>40</volume><year>2025</year><fpage>S48</fpage><lpage>S49</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2024.10.035</pub-id><pub-id pub-id-type="pmid">39424244</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>J.R.L.</given-names></name><name name-style="western"><surname>Metcalf</surname><given-names>R.</given-names></name><name name-style="western"><surname>Leisinger</surname><given-names>E.</given-names></name><name name-style="western"><surname>An</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Bedard</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>T.S.</given-names></name></person-group><article-title>Does smoking cessation prior to elective total joint arthroplasty result in continued abstinence?</article-title><source>Iowa Orthop J</source><volume>41</volume><year>2021</year><fpage>141</fpage><lpage>144</lpage><pub-id pub-id-type="pmid">34552416</pub-id><pub-id pub-id-type="pmcid">PMC8259204</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name name-style="western"><surname>Silverstein</surname><given-names>P.</given-names></name></person-group><article-title>Smoking and wound healing</article-title><source>Am J Med</source><volume>93</volume><year>1992</year><fpage>22S</fpage><lpage>24S</lpage><pub-id pub-id-type="doi">10.1016/0002-9343(92)90623-j</pub-id><pub-id pub-id-type="pmid">1323208</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name name-style="western"><surname>Valdez-Miramontes</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Trejo Mart&#237;nez</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Torres-Ju&#225;rez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rodr&#237;guez Carlos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Marin-Lu&#233;vano</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>de Haro-Acosta</surname><given-names>J.P.</given-names></name><etal/></person-group><article-title>Nicotine modulates molecules of the innate immune response in epithelial cells and macrophages during infection with M. tuberculosis</article-title><source>Clin Exp Immunol</source><volume>199</volume><year>2020</year><fpage>230</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1111/cei.13388</pub-id><pub-id pub-id-type="pmid">31631328</pub-id><pub-id pub-id-type="pmcid">PMC6954679</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name name-style="western"><surname>McAllister-Sistilli</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Caggiula</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>Knopf</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rose</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Donny</surname><given-names>E.C.</given-names></name></person-group><article-title>The effects of nicotine on the immune system</article-title><source>Psychoneuroendocrinology</source><volume>23</volume><year>1998</year><fpage>175</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/s0306-4530(97)00080-2</pub-id><pub-id pub-id-type="pmid">9621397</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name name-style="western"><surname>Schneller</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Felicione</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Hammond</surname><given-names>D.</given-names></name><name name-style="western"><surname>Goniewicz</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>O&#8217;Connor</surname><given-names>R.J.</given-names></name></person-group><article-title>Tobacco-free oral nicotine product use among youth in the U.S., 2019-2021</article-title><source>AJPM Focus</source><volume>2</volume><year>2023</year><object-id pub-id-type="publisher-id">100061</object-id><pub-id pub-id-type="doi">10.1016/j.focus.2022.100061</pub-id><pub-id pub-id-type="pmcid">PMC10546555</pub-id><pub-id pub-id-type="pmid">37789938</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name name-style="western"><surname>Kramarow</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Elgaddal</surname><given-names>N.</given-names></name></person-group><article-title>Current electronic cigarette use among adults aged 18 and over: United States, 2021</article-title><source>NCHS Data Brief</source><year>2023</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">37486729</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name name-style="western"><surname>Bieganowski</surname><given-names>T.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kugelman</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>Rozell</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Schwarzkopf</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lajam</surname><given-names>C.M.</given-names></name></person-group><article-title>Vaping trends and outcomes in primary total joint arthroplasty patients: an analysis of 21,341 patients</article-title><source>J Am Acad Orthop Surg Glob Res Rev</source><volume>7</volume><year>2023</year><object-id pub-id-type="publisher-id">e22.00110</object-id><pub-id pub-id-type="doi">10.5435/JAAOSGlobal-D-22-00110</pub-id><pub-id pub-id-type="pmcid">PMC9842224</pub-id><pub-id pub-id-type="pmid">36649131</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name name-style="western"><surname>Mishra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Chaturvedi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Datta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sinukumar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Garg</surname><given-names>A.</given-names></name></person-group><article-title>Harmful effects of nicotine</article-title><source>Indian J Med Paediatr Oncol</source><volume>36</volume><year>2015</year><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.4103/0971-5851.151771</pub-id><pub-id pub-id-type="pmid">25810571</pub-id><pub-id pub-id-type="pmcid">PMC4363846</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name name-style="western"><surname>Reilly</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Bitzer</surname><given-names>Z.T.</given-names></name><name name-style="western"><surname>Goel</surname><given-names>R.</given-names></name><name name-style="western"><surname>Trushin</surname><given-names>N.</given-names></name><name name-style="western"><surname>Richie</surname><given-names>J.P.</given-names></name></person-group><article-title>Free radical, carbonyl, and nicotine levels produced by juul electronic cigarettes</article-title><source>Nicotine Tob Res</source><volume>21</volume><year>2019</year><fpage>1274</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1093/ntr/nty221</pub-id><pub-id pub-id-type="pmid">30346584</pub-id><pub-id pub-id-type="pmcid">PMC7182768</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name name-style="western"><surname>Kopa-Stojak</surname><given-names>P.N.</given-names></name><name name-style="western"><surname>Pawliczak</surname><given-names>R.</given-names></name></person-group><article-title>Comparison of the effects of active and passive smoking of tobacco cigarettes, electronic nicotine delivery systems and tobacco heating products on the expression and secretion of oxidative stress and inflammatory response markers. A systematic review</article-title><source>Inhal Toxicol</source><volume>36</volume><year>2024</year><fpage>75</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1080/08958378.2024.2319315</pub-id><pub-id pub-id-type="pmid">38394073</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name name-style="western"><surname>DeShazo</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Crossnoe</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Naeger</surname><given-names>P.A.</given-names></name></person-group><article-title>Non-tobacco nicotine dependence and rates of postoperative complications in total knee arthroplasty: a propensity-matched comparison</article-title><source>J Am Acad Orthop Surg</source><volume>32</volume><year>2024</year><fpage>1032</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.5435/JAAOS-D-23-01053</pub-id><pub-id pub-id-type="pmid">38713764</pub-id><pub-id pub-id-type="pmcid">PMC11530330</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="other" id="sref25"><article-title>Anon. TriNetX</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://live.trinetx.com/" id="intref0020">https://live.trinetx.com/</ext-link></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name name-style="western"><surname>Palchuk</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>London</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Perez-Rey</surname><given-names>D.</given-names></name><name name-style="western"><surname>Drebert</surname><given-names>Z.J.</given-names></name><name name-style="western"><surname>Winer-Jones</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>C.N.</given-names></name><etal/></person-group><article-title>A global federated real-world data and analytics platform for research</article-title><source>JAMIA Open</source><volume>6</volume><year>2023</year><object-id pub-id-type="publisher-id">ooad035</object-id><pub-id pub-id-type="doi">10.1093/jamiaopen/ooad035</pub-id><pub-id pub-id-type="pmcid">PMC10182857</pub-id><pub-id pub-id-type="pmid">37193038</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Omar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>X.</given-names></name><name name-style="western"><surname>Neunaber</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jagodzinski</surname><given-names>M.</given-names></name></person-group><article-title>Impact of smoking on the incidence and post-operative complications of total knee arthroplasty: a systematic review and meta-analysis of cohort studies</article-title><source>Bosn J Basic Med Sci</source><volume>22</volume><year>2022</year><fpage>353</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.17305/bjbms.2021.6538</pub-id><pub-id pub-id-type="pmid">34923952</pub-id><pub-id pub-id-type="pmcid">PMC9162741</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="other" id="sref28"><person-group person-group-type="author"><name name-style="western"><surname>Lawand</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ghali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hauck</surname><given-names>J.</given-names></name><name name-style="western"><surname>Trejo Corona</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Deveza</surname><given-names>L.</given-names></name></person-group><article-title>The smokeless paradox: nontobacco nicotine use and complications in anterior cervical discectomy and fusion. JAAOS - J Am acad orthop surg</article-title><comment>Published online 9900</comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://journals.lww.com/jaaos/fulltext/9900/the_smokeless_paradox__nontobacco_nicotine_use_and.1193.aspx" id="intref0025">https://journals.lww.com/jaaos/fulltext/9900/the_smokeless_paradox__nontobacco_nicotine_use_and.1193.aspx</ext-link><pub-id pub-id-type="doi" assigning-authority="pmc">10.5435/JAAOS-D-24-00801</pub-id><pub-id pub-id-type="pmid">39705814</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name name-style="western"><surname>Lawand</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ghali</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dajani</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Boufadel</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bey</surname><given-names>H.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Abboud</surname><given-names>J.</given-names></name></person-group><article-title>Nontobacco nicotine dependence and rates of periprosthetic joint infection and other postoperative complications in shoulder arthroplasty: a retrospective analysis</article-title><source>J Am Acad Orthop Surg</source><volume>33</volume><year>2025</year><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.5435/JAAOS-D-24-00706</pub-id><pub-id pub-id-type="pmid">39348556</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name name-style="western"><surname>Heckmann</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Haque</surname><given-names>T.F.</given-names></name><name name-style="western"><surname>Piple</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Mayfield</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Bouz</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>L.W.</given-names></name><etal/></person-group><article-title>Tranexamic acid and prothrombotic complications following total hip and total knee arthroplasty: a population-wide safety analysis accounting for surgeon selection bias</article-title><source>J Arthroplasty</source><volume>38</volume><year>2023</year><fpage>215</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2022.08.026</pub-id><pub-id pub-id-type="pmid">36007755</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name name-style="western"><surname>Hadad</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Grits</surname><given-names>D.</given-names></name><name name-style="western"><surname>Emara</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Orr</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Piuzzi</surname><given-names>N.S.</given-names></name></person-group><article-title>Trends in prevalence and complications for smokers who underwent total hip arthroplasty from 2011 to 2019: an analysis of 243,163 patients</article-title><source>HIP Int</source><volume>34</volume><year>2024</year><fpage>432</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1177/11207000241230272</pub-id><pub-id pub-id-type="pmid">38372159</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Lewallen</surname><given-names>D.G.</given-names></name></person-group><article-title>Ninety-day mortality in patients undergoing elective total hip or total knee arthroplasty</article-title><source>J Arthroplasty</source><volume>27</volume><year>2012</year><fpage>1417</fpage><lpage>1422.e1</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2012.03.008</pub-id><pub-id pub-id-type="pmid">22554727</pub-id><pub-id pub-id-type="pmcid">PMC3413788</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name name-style="western"><surname>Aynardi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pulido</surname><given-names>L.</given-names></name><name name-style="western"><surname>Parvizi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sharkey</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Rothman</surname><given-names>R.H.</given-names></name></person-group><article-title>Early mortality after modern total hip arthroplasty</article-title><source>Clin Orthop</source><volume>467</volume><year>2009</year><fpage>213</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1007/s11999-008-0528-5</pub-id><pub-id pub-id-type="pmid">18846410</pub-id><pub-id pub-id-type="pmcid">PMC2600973</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name name-style="western"><surname>Clement</surname><given-names>N.D.</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Brenkel</surname><given-names>I.J.</given-names></name><name name-style="western"><surname>Walmsley</surname><given-names>P.</given-names></name></person-group><article-title>Predictors of mortality after total knee replacement: a ten-year survivorship analysis</article-title><source>J Bone Joint Surg Br</source><volume>94</volume><year>2012</year><fpage>200</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.94B2.28114</pub-id><pub-id pub-id-type="pmid">22323686</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name name-style="western"><surname>Soohoo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Farng</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zingmond</surname><given-names>D.</given-names></name></person-group><article-title>Factors that predict short-term complication rates after total hip arthroplasty</article-title><source>Clin Orthop</source><volume>468</volume><year>2010</year><fpage>2363</fpage><lpage>2371</lpage><pub-id pub-id-type="doi">10.1007/s11999-010-1354-0</pub-id><pub-id pub-id-type="pmid">20428982</pub-id><pub-id pub-id-type="pmcid">PMC2914297</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>N.M.</given-names></name><name name-style="western"><surname>Varnum</surname><given-names>C.</given-names></name><name name-style="western"><surname>Overgaard</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>A.B.</given-names></name></person-group><article-title>Impact of socioeconomic status on the 90- and 365-day rate of revision and mortality after primary total hip arthroplasty: a cohort study based on 103,901 patients with osteoarthritis from national databases in Denmark</article-title><source>Acta Orthop</source><volume>92</volume><year>2021</year><fpage>581</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1080/17453674.2021.1935487</pub-id><pub-id pub-id-type="pmid">34085592</pub-id><pub-id pub-id-type="pmcid">PMC8519516</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name name-style="western"><surname>Bongers</surname><given-names>J.</given-names></name><name name-style="western"><surname>Belt</surname><given-names>M.</given-names></name><name name-style="western"><surname>Spekenbrink-Spooren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Smulders</surname><given-names>K.</given-names></name><name name-style="western"><surname>Schreurs</surname><given-names>B.W.</given-names></name><name name-style="western"><surname>Koeter</surname><given-names>S.</given-names></name></person-group><article-title>Smoking is associated with higher short-term risk of revision and mortality following primary hip or knee arthroplasty: a cohort study of 272,640 patients from the Dutch Arthroplasty Registry</article-title><source>Acta Orthop</source><volume>95</volume><year>2024</year><fpage>114</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.2340/17453674.2024.39966</pub-id><pub-id pub-id-type="pmid">38353549</pub-id><pub-id pub-id-type="pmcid">PMC10866148</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name name-style="western"><surname>Teng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Krettek</surname><given-names>C.</given-names></name><name name-style="western"><surname>Jagodzinski</surname><given-names>M.</given-names></name></person-group><article-title>Smoking and risk of prosthesis-related complications after total hip arthroplasty: a meta-analysis of cohort studies</article-title><source>PLoS One</source><volume>10</volume><year>2015</year><object-id pub-id-type="publisher-id">e0125294</object-id><pub-id pub-id-type="doi">10.1371/journal.pone.0125294</pub-id><pub-id pub-id-type="pmcid">PMC4409354</pub-id><pub-id pub-id-type="pmid">25909602</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name name-style="western"><surname>Herrero</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wasterlain</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sherman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bosco</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lajam</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Smoking cessation correlates with a decrease in infection rates following total joint arthroplasty</article-title><source>J Orthop</source><volume>21</volume><year>2020</year><fpage>390</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.jor.2020.08.026</pub-id><pub-id pub-id-type="pmid">32921947</pub-id><pub-id pub-id-type="pmcid">PMC7475516</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="other" id="sref40"><person-group person-group-type="author"><collab>AAOS</collab></person-group><article-title>Perioperative Risk factors; quality programs and guidelines</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://aaos.org/quality/quality-programs/quality-toolkits/smoking/" id="intref0030">https://aaos.org/quality/quality-programs/quality-toolkits/smoking/</ext-link><year>2022</year></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Dirkes</surname><given-names>J.E.H.</given-names></name><name name-style="western"><surname>Aronson</surname><given-names>S.</given-names></name></person-group><article-title>A systematic approach to perioperative smoking cessation</article-title><source>Tech Orthop</source><volume>35</volume><year>2020</year><fpage>25</fpage><lpage>30</lpage></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name name-style="western"><surname>Pierre</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rivera</surname><given-names>C.</given-names></name><name name-style="western"><surname>Le Ma&#238;.tre</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wirth</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Guidelines on smoking management during the perioperative period</article-title><source>Anaesth Crit Care Pain Med</source><volume>36</volume><year>2017</year><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/j.accpm.2017.02.002</pub-id><pub-id pub-id-type="pmid">28238936</pub-id></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary data</title><p id="p0120">
<supplementary-material content-type="local-data" id="mmc1" position="float" orientation="portrait"><caption><title>Supplementary Table 1</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc1.docx" position="float" orientation="portrait"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc2" position="float" orientation="portrait"><caption><title>Conflict of Interest Statement for Berk</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc2.docx" position="float" orientation="portrait"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc3" position="float" orientation="portrait"><caption><title>Conflict of Interest Statement for Blackburn</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc3.pdf" position="float" orientation="portrait"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc4" position="float" orientation="portrait"><caption><title>Conflict of Interest Statement for Jawanda</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc4.docx" position="float" orientation="portrait"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc5" position="float" orientation="portrait"><caption><title>Conflict of Interest Statement for Adelstein</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc5.docx" position="float" orientation="portrait"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc6" position="float" orientation="portrait"><caption><title>Conflict of Interest Statement for Good</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc6.docx" position="float" orientation="portrait"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc7" position="float" orientation="portrait"><caption><title>Conflict of Interest Statement for Florentino</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc7.docx" position="float" orientation="portrait"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc8" position="float" orientation="portrait"><caption><title>Conflict of Interest Statement for Cohen-Levy</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc8.docx" position="float" orientation="portrait"/></supplementary-material>
</p></sec><fn-group><fn id="appsec2" fn-type="supplementary-material"><p id="p0125">Supplementary data related to this article can be found at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.artd.2025.101743" id="intref0015">https://doi.org/10.1016/j.artd.2025.101743</ext-link>.</p></fn></fn-group></back></article></pmc-articleset>